nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—ureter—kidney cancer	0.0789	0.865	CbGeAlD
Methylscopolamine bromide—Ageusia—Temsirolimus—kidney cancer	0.0355	0.039	CcSEcCtD
Methylscopolamine bromide—Ageusia—Pazopanib—kidney cancer	0.0334	0.0368	CcSEcCtD
Methylscopolamine bromide—Ageusia—Everolimus—kidney cancer	0.0264	0.029	CcSEcCtD
Methylscopolamine bromide—Ageusia—Sunitinib—kidney cancer	0.022	0.0242	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Temsirolimus—kidney cancer	0.0181	0.02	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Pazopanib—kidney cancer	0.0171	0.0188	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Everolimus—kidney cancer	0.0135	0.0149	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Everolimus—kidney cancer	0.0123	0.0136	CcSEcCtD
Methylscopolamine bromide—Ageusia—Capecitabine—kidney cancer	0.0121	0.0134	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Sunitinib—kidney cancer	0.0113	0.0124	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Pazopanib—kidney cancer	0.0112	0.0123	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Sorafenib—kidney cancer	0.0107	0.0118	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Temsirolimus—kidney cancer	0.0102	0.0113	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Pazopanib—kidney cancer	0.00985	0.0108	CcSEcCtD
Methylscopolamine bromide—Insomnia—Temsirolimus—kidney cancer	0.00927	0.0102	CcSEcCtD
Methylscopolamine bromide—Somnolence—Temsirolimus—kidney cancer	0.00911	0.01	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Everolimus—kidney cancer	0.0088	0.00969	CcSEcCtD
Methylscopolamine bromide—Constipation—Temsirolimus—kidney cancer	0.00877	0.00965	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pazopanib—kidney cancer	0.00873	0.00961	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Vincristine—kidney cancer	0.00872	0.0096	CcSEcCtD
Methylscopolamine bromide—Somnolence—Pazopanib—kidney cancer	0.00858	0.00945	CcSEcCtD
Methylscopolamine bromide—Palpitations—Everolimus—kidney cancer	0.00826	0.00909	CcSEcCtD
Methylscopolamine bromide—Ageusia—Doxorubicin—kidney cancer	0.00783	0.00862	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Everolimus—kidney cancer	0.00778	0.00856	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Paclitaxel—kidney cancer	0.00757	0.00833	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Temsirolimus—kidney cancer	0.00755	0.00831	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Everolimus—kidney cancer	0.00744	0.00819	CcSEcCtD
Methylscopolamine bromide—Asthenia—Temsirolimus—kidney cancer	0.00735	0.00809	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pazopanib—kidney cancer	0.00693	0.00762	CcSEcCtD
Methylscopolamine bromide—Insomnia—Everolimus—kidney cancer	0.0069	0.00759	CcSEcCtD
Methylscopolamine bromide—Somnolence—Everolimus—kidney cancer	0.00678	0.00746	CcSEcCtD
Methylscopolamine bromide—Dizziness—Temsirolimus—kidney cancer	0.00678	0.00746	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Sorafenib—kidney cancer	0.00675	0.00743	CcSEcCtD
Methylscopolamine bromide—Insomnia—Erlotinib—kidney cancer	0.00665	0.00732	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Sorafenib—kidney cancer	0.00662	0.00728	CcSEcCtD
Methylscopolamine bromide—Constipation—Vinblastine—kidney cancer	0.00655	0.0072	CcSEcCtD
Methylscopolamine bromide—Constipation—Everolimus—kidney cancer	0.00652	0.00718	CcSEcCtD
Methylscopolamine bromide—Vomiting—Temsirolimus—kidney cancer	0.00652	0.00717	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Sunitinib—kidney cancer	0.0065	0.00715	CcSEcCtD
Methylscopolamine bromide—Headache—Temsirolimus—kidney cancer	0.00642	0.00707	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pazopanib—kidney cancer	0.00639	0.00703	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vinblastine—kidney cancer	0.00631	0.00694	CcSEcCtD
Methylscopolamine bromide—Constipation—Erlotinib—kidney cancer	0.00629	0.00692	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Everolimus—kidney cancer	0.00628	0.00691	CcSEcCtD
Methylscopolamine bromide—CHRM3—renal system—kidney cancer	0.00628	0.0687	CbGeAlD
Methylscopolamine bromide—Abdominal distension—Capecitabine—kidney cancer	0.00622	0.00684	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pazopanib—kidney cancer	0.00614	0.00676	CcSEcCtD
Methylscopolamine bromide—Nausea—Temsirolimus—kidney cancer	0.00609	0.0067	CcSEcCtD
Methylscopolamine bromide—CHRM3—kidney—kidney cancer	0.00607	0.0665	CbGeAlD
Methylscopolamine bromide—Headache—Pazopanib—kidney cancer	0.00605	0.00666	CcSEcCtD
Methylscopolamine bromide—Insomnia—Sunitinib—kidney cancer	0.00576	0.00634	CcSEcCtD
Methylscopolamine bromide—Nausea—Pazopanib—kidney cancer	0.00574	0.00631	CcSEcCtD
Methylscopolamine bromide—Constipation—Sorafenib—kidney cancer	0.00566	0.00623	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinblastine—kidney cancer	0.00564	0.00621	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Everolimus—kidney cancer	0.00562	0.00618	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vinblastine—kidney cancer	0.00549	0.00604	CcSEcCtD
Methylscopolamine bromide—Asthenia—Everolimus—kidney cancer	0.00547	0.00602	CcSEcCtD
Methylscopolamine bromide—Constipation—Sunitinib—kidney cancer	0.00545	0.00599	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Vincristine—kidney cancer	0.00539	0.00593	CcSEcCtD
Methylscopolamine bromide—Asthenia—Erlotinib—kidney cancer	0.00528	0.00581	CcSEcCtD
Methylscopolamine bromide—Urticaria—Sorafenib—kidney cancer	0.00526	0.00579	CcSEcCtD
Methylscopolamine bromide—Tension—Paclitaxel—kidney cancer	0.00514	0.00566	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Gemcitabine—kidney cancer	0.00511	0.00562	CcSEcCtD
Methylscopolamine bromide—Nervousness—Paclitaxel—kidney cancer	0.00509	0.0056	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vinblastine—kidney cancer	0.00506	0.00557	CcSEcCtD
Methylscopolamine bromide—Dizziness—Everolimus—kidney cancer	0.00504	0.00555	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dactinomycin—kidney cancer	0.00497	0.00547	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Paclitaxel—kidney cancer	0.00494	0.00544	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Sorafenib—kidney cancer	0.00488	0.00537	CcSEcCtD
Methylscopolamine bromide—Insomnia—Vincristine—kidney cancer	0.00487	0.00536	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinblastine—kidney cancer	0.00487	0.00536	CcSEcCtD
Methylscopolamine bromide—Dizziness—Erlotinib—kidney cancer	0.00486	0.00535	CcSEcCtD
Methylscopolamine bromide—Vomiting—Everolimus—kidney cancer	0.00485	0.00533	CcSEcCtD
Methylscopolamine bromide—Headache—Vinblastine—kidney cancer	0.00479	0.00528	CcSEcCtD
Methylscopolamine bromide—Headache—Everolimus—kidney cancer	0.00478	0.00526	CcSEcCtD
Methylscopolamine bromide—Asthenia—Sorafenib—kidney cancer	0.00475	0.00523	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Sunitinib—kidney cancer	0.00469	0.00516	CcSEcCtD
Methylscopolamine bromide—Vomiting—Erlotinib—kidney cancer	0.00468	0.00515	CcSEcCtD
Methylscopolamine bromide—Palpitations—Paclitaxel—kidney cancer	0.00463	0.0051	CcSEcCtD
Methylscopolamine bromide—Insomnia—Gemcitabine—kidney cancer	0.00462	0.00509	CcSEcCtD
Methylscopolamine bromide—Headache—Erlotinib—kidney cancer	0.00461	0.00507	CcSEcCtD
Methylscopolamine bromide—Constipation—Vincristine—kidney cancer	0.00461	0.00507	CcSEcCtD
Methylscopolamine bromide—Asthenia—Sunitinib—kidney cancer	0.00457	0.00503	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinblastine—kidney cancer	0.00455	0.005	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gemcitabine—kidney cancer	0.00454	0.005	CcSEcCtD
Methylscopolamine bromide—Nausea—Everolimus—kidney cancer	0.00453	0.00498	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Dactinomycin—kidney cancer	0.00444	0.00489	CcSEcCtD
Methylscopolamine bromide—Dizziness—Sorafenib—kidney cancer	0.00438	0.00482	CcSEcCtD
Methylscopolamine bromide—Constipation—Gemcitabine—kidney cancer	0.00437	0.00481	CcSEcCtD
Methylscopolamine bromide—Nausea—Erlotinib—kidney cancer	0.00437	0.00481	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Paclitaxel—kidney cancer	0.00436	0.0048	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dactinomycin—kidney cancer	0.00433	0.00476	CcSEcCtD
Methylscopolamine bromide—Confusional state—Paclitaxel—kidney cancer	0.00431	0.00475	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Paclitaxel—kidney cancer	0.00428	0.00471	CcSEcCtD
Methylscopolamine bromide—Dizziness—Sunitinib—kidney cancer	0.00421	0.00463	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gemcitabine—kidney cancer	0.00421	0.00463	CcSEcCtD
Methylscopolamine bromide—Vomiting—Sorafenib—kidney cancer	0.00421	0.00463	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Paclitaxel—kidney cancer	0.00418	0.0046	CcSEcCtD
Methylscopolamine bromide—Headache—Sorafenib—kidney cancer	0.00415	0.00456	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Capecitabine—kidney cancer	0.00405	0.00446	CcSEcCtD
Methylscopolamine bromide—Vomiting—Sunitinib—kidney cancer	0.00405	0.00446	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—kidney cancer	0.00401	0.00441	CcSEcCtD
Methylscopolamine bromide—Headache—Sunitinib—kidney cancer	0.00399	0.00439	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vincristine—kidney cancer	0.00397	0.00437	CcSEcCtD
Methylscopolamine bromide—Nausea—Sorafenib—kidney cancer	0.00393	0.00433	CcSEcCtD
Methylscopolamine bromide—Insomnia—Paclitaxel—kidney cancer	0.00387	0.00426	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vincristine—kidney cancer	0.00386	0.00425	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dactinomycin—kidney cancer	0.00383	0.00422	CcSEcCtD
Methylscopolamine bromide—Somnolence—Paclitaxel—kidney cancer	0.0038	0.00419	CcSEcCtD
Methylscopolamine bromide—Palpitations—Capecitabine—kidney cancer	0.0038	0.00418	CcSEcCtD
Methylscopolamine bromide—Nausea—Sunitinib—kidney cancer	0.00378	0.00416	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gemcitabine—kidney cancer	0.00367	0.00403	CcSEcCtD
Methylscopolamine bromide—Constipation—Paclitaxel—kidney cancer	0.00366	0.00403	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Capecitabine—kidney cancer	0.00358	0.00394	CcSEcCtD
Methylscopolamine bromide—Nausea—Dactinomycin—kidney cancer	0.00358	0.00394	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vincristine—kidney cancer	0.00356	0.00392	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—kidney cancer	0.00355	0.0039	CcSEcCtD
Methylscopolamine bromide—Confusional state—Capecitabine—kidney cancer	0.00354	0.0039	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Paclitaxel—kidney cancer	0.00353	0.00388	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Capecitabine—kidney cancer	0.00343	0.00377	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vincristine—kidney cancer	0.00342	0.00377	CcSEcCtD
Methylscopolamine bromide—Urticaria—Paclitaxel—kidney cancer	0.0034	0.00374	CcSEcCtD
Methylscopolamine bromide—Headache—Vincristine—kidney cancer	0.00337	0.00371	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gemcitabine—kidney cancer	0.00325	0.00358	CcSEcCtD
Methylscopolamine bromide—Headache—Gemcitabine—kidney cancer	0.0032	0.00352	CcSEcCtD
Methylscopolamine bromide—Nausea—Vincristine—kidney cancer	0.0032	0.00352	CcSEcCtD
Methylscopolamine bromide—Insomnia—Capecitabine—kidney cancer	0.00318	0.00349	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Paclitaxel—kidney cancer	0.00315	0.00347	CcSEcCtD
Methylscopolamine bromide—Asthenia—Paclitaxel—kidney cancer	0.00307	0.00338	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemcitabine—kidney cancer	0.00304	0.00334	CcSEcCtD
Methylscopolamine bromide—Constipation—Capecitabine—kidney cancer	0.003	0.0033	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Capecitabine—kidney cancer	0.00289	0.00318	CcSEcCtD
Methylscopolamine bromide—Dizziness—Paclitaxel—kidney cancer	0.00283	0.00311	CcSEcCtD
Methylscopolamine bromide—Urticaria—Capecitabine—kidney cancer	0.00279	0.00307	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—kidney cancer	0.00272	0.00299	CcSEcCtD
Methylscopolamine bromide—Vomiting—Paclitaxel—kidney cancer	0.00272	0.00299	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—kidney cancer	0.00269	0.00296	CcSEcCtD
Methylscopolamine bromide—Headache—Paclitaxel—kidney cancer	0.00268	0.00295	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—kidney cancer	0.00261	0.00288	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Capecitabine—kidney cancer	0.00259	0.00285	CcSEcCtD
Methylscopolamine bromide—Nausea—Paclitaxel—kidney cancer	0.00254	0.0028	CcSEcCtD
Methylscopolamine bromide—Asthenia—Capecitabine—kidney cancer	0.00252	0.00277	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—kidney cancer	0.00245	0.0027	CcSEcCtD
Methylscopolamine bromide—Dizziness—Capecitabine—kidney cancer	0.00232	0.00255	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—kidney cancer	0.00231	0.00254	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—kidney cancer	0.00228	0.00251	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—kidney cancer	0.00226	0.00249	CcSEcCtD
Methylscopolamine bromide—Vomiting—Capecitabine—kidney cancer	0.00223	0.00246	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—kidney cancer	0.00221	0.00243	CcSEcCtD
Methylscopolamine bromide—Headache—Capecitabine—kidney cancer	0.0022	0.00242	CcSEcCtD
Methylscopolamine bromide—Nausea—Capecitabine—kidney cancer	0.00209	0.00229	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—kidney cancer	0.00205	0.00225	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—kidney cancer	0.00201	0.00221	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—kidney cancer	0.00194	0.00213	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—kidney cancer	0.00186	0.00205	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—kidney cancer	0.0018	0.00198	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—kidney cancer	0.00167	0.00183	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—kidney cancer	0.00162	0.00179	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—kidney cancer	0.0015	0.00165	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—kidney cancer	0.00144	0.00158	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—kidney cancer	0.00142	0.00156	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—kidney cancer	0.00134	0.00148	CcSEcCtD
